| 261 |
NOVEL MOLECULAR DIAGNOSTIC MARKER IN EVALUATION OF CARTILAGE DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
2016 |
| 262 |
NOVEL MOLECULAR DIAGNOSTIC MARKER IN EVALUATION OF CARTILAGE DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
2016 |
| 263 |
NOVEL MOLECULAR DIAGNOSTIC MARKER IN EVALUATION OF CARTILAGE DESTRUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
2016 |
| 264 |
Relation between serum leptin concentration and insulin resistance syndrome in Patients with Type 2 Diabetes Mellius |
2016 |
| 265 |
Relation between serum leptin concentration and insulin resistance syndrome in Patients with Type 2 Diabetes Mellius |
2016 |
| 266 |
Resistant Hypertension in Hemodialysis Patients |
2016 |
| 267 |
Resistant Hypertension in Hemodialysis Patients |
2016 |
| 268 |
Resistant Hypertension in Hemodialysis Patients |
2016 |
| 269 |
Serum and Urinary Biomarkers Endothelin-1, Beta-2 Microglobulin, Cystatin C, Galectin-3 and Alpha-1-acid Glycoprotein; Can they Surrogate Clinical and Histological Staging in Lupus Nephritis Patients |
2016 |
| 270 |
Serum and Urinary Biomarkers Endothelin-1, Beta-2 Microglobulin, Cystatin C, Galectin-3 and Alpha-1-acid Glycoprotein; Can they Surrogate Clinical and Histological Staging in Lupus Nephritis Patients |
2016 |